Incyte Corp | 75.99 / -0.67% |
Date/Time | 05/26 / 21:59 |
Chg. / Chg.(%) | -0.51 / -0.67% |
Bid | - |
Ask | - |
Open | 76.88 |
Previous Close | 76.50 |
High | 77.60 |
Low | 75.86 |
Volume [USD] | 2,721,888.37 |
Volume [Units] | 35,606 |
Price fixings | 1901 |
ISIN | US45337C1027 |
Security | INCY |
Exchange | IEX |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 69.74 | ![]() |
|
NASDAQ | 76.0200 | ![]() |
845,955 |
Cboe US | 76.01 | ![]() |
38,074 |
IEX | 75.99 | ![]() |
35,606 |
London Domes.. | 76.88 | ![]() |
343 |
TradeGate | 71.920 | ![]() |
279 |
Mexico | 1,532.00 | ![]() |
85 |
Hannover | 71.05 | ![]() |
0 |
Frankfurt | 71.4700 | ![]() |
0 |
München | 71.48 | ![]() |
0 |
Düsseldorf | 71.97 | ![]() |
0 |
Berlin | 71.20 | ![]() |
0 |
Stuttgart | 70.740 | ![]() |
0 |
Quotrix | 72.3700 | ![]() |
|
gettex | 71.100 | ![]() |
News
- RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation Annual Scientific Symposium
03/23/2022 / 21:01 - GlobeNewswire - STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations
03/14/2022 / 21:05 - GlobeNewswire - Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus Retifanlimab as Investigational First Line Therapy for Patients With Advanced Pancreatic Cancer
03/01/2022 / 13:55 - GlobeNewswire - Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Update
02/28/2022 / 22:36 - GlobeNewswire - MacroGenics Provides Update on Corporate Progress and 2021 Financial Results
02/24/2022 / 22:01 - GlobeNewswire
Personal area
Click on
to activate push quotes.
